Randomized clinical trial of PCR-determined human papillomavirus detection methods: Self-sampling versus clinician-directed-biologic concordance and women's preferences

American Journal of Obstetrics and Gynecology

Volumn 186, Issue 3, 2002, Pages 365-373

  Harper, Diane M ^a   Noll, Walter W ^a   Belloni, Dorothy R ^a   Cole, Bernard F ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Acceptability; Human papillomavirus; Screening; Self sampling; Swab

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLING; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; WART VIRUS;

EID: 0036130422     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.121076     Document Type: Article

References (25)

1. Human papillomaviruses
2. Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal Papanicolaou results
3. Assessing gains in diagnostic utility when human papillomavirus testing is used as an adjunct to Papanicolaou smear in the triage of women with cervical cytologic abnormalities
4. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses
5. Hybrid capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: A preliminary study on 1518 women
6. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer
7. HPV DNA testing in cervical cancer screening results from women in a high-risk province of Costa Rica
8. Human papillomavirus testing for primary cervical cancer screening
9. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings
10. Tampons: A novel patient-administered method for the assessment of genital human papillomavirus infection
11. Molecular diagnosis of genital human papillomavirus infection: Comparison of two methods used to collect exfoliated cervical cells
12. Self-administered home cervicovaginal lavage: A novel tool for the clinical-epidemiologic investigation of genital human papillomavirus infections
13. Comparison between methods for human papillomavirus DNA testing: A model for self-testing in young women
14. Comparison of cytobrush and cervicovaginal lavage sampling methods for the detection of genital human papillomavirus
15. Identification of human papillomavirus in cervical swabs by deoxyribonucleic acid in situ hybridization
16. Comparison between vaginal tampon and cervicovaginal lavage specimen collection for detection of human papillomavirus DNA by the polymerase chain reaction: The Canadian Women's HIV Study Group
17. Collection techniques for human papillomavirus
18. Screening for cervical neoplasia by self-assessment for human papillomasirus DNA
19. Determination of genital human papillomavirus infection using consensus PCR
20. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method
21. Missed opportunities of cervical cancer screening of HMO members developing invasive cervical cancer (ICC)
22. Evaluation of self-collected cervicovaginal cells samples for human papillomavirus testing by PCR
23. The use of tampons for identifying asymptomatic N. gonorrhoeae infections
24. Evaluation of vaginal tampons for collection of specimens for detection of Chlamydial infection
25. Self-administered tampons can be used to diagnose sexually transmitted diseases